Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack

Similar documents
POST EVENT REPORT IP Life Sciences Exchange 2015

Corporate Compliance & Transparency

Method of Declaration. Hospitality/Interest/Sponsorship

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

Research Brief. Clinicians and life sciences companies working together: What types of relationships do clinicians find most appealing?

2017 IPCC Attendee List

SPONSORSHIP OPPORTUNITIES

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

Early Valuation. Company Portfolio

Tecan Group. Corporate Update CONFERENCE CALL JANUARY 15, 2019

Advancing the business of intellectual property globally.

CDP-EIF ITAtech Equity Platform

NVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations

Patent Documentation Group

Filing strategies in Europe

1. Introduction. defining and producing new materials with advanced properties, or optimizing industrial processes.

Welcome to Althea. Welcome to the future of integrated healthcare technology management

Does exposure to university research matter to high-potential entrepreneurship?

The 2011 EU industrial R&D investment SCOREBOARD

Inclusion Women at the Forefront of STEM

Welcome to the IFR Press Conference 30 August 2012, Taipei

Call for proposals to host. the. Ecsite Directors Forum 2015 or Ecsite Directors Forum 2016

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.

Compliance for Eucomed: The Medical Technology Industry s s Perspective

SPONSORSHIP OPPORTUNITIES

OBN BioTuesday: Sources of Public Non-Dilutable Funding & Export Support to UK R&D Companies

Public Private Partnerships & Idea selection

Accelerating growth in a connected Mediterranean region

International Presence, Local Expertise. Introductory Presentation

Berlin Summit, Hotel Adlon Kempinski, April 26-27, 2012

Technology First. Make India Innovate, Excel Globally and Prosper. 5-6 September 2018

Presented by the Texas Gulf Coast Chapter. Norris Conference Center Houston/CityCentre Thursday, April 12, :00am-6:00pm

European Patent Reform Forum USA December , New York

TRENDS IN IP DISPUTES

Allen Norris Vice President Head of Group IP UCB Pharma SA Belgium

Industrial Investment in Research and Development: Trends and Prospects

Pharma-Bio-Med 2006 Conference & Exposition Detailed Programme

BREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

5 th Annual Pharma IPR Conference 2016

May 13, 2015 London Life Sciences College Cristina Menendez Ruiz

Treasury and Trade Solutions Citi Commercial Cards. A History of Achievement. A Future of Innovation. May 19-21, 2014

OECD s Innovation Strategy: Key Findings and Policy Messages

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

OECD Science, Technology and Industry Outlook 2010 Highlights

Automated Frequency Response Measurement with AFG31000, MDO3000 and TekBench Instrument Control Software APPLICATION NOTE

Lundbeck s view on the EU IP systems

Trouble-shooting Radio Links in Unlicensed Frequency Bands TUTORIAL

Patent Masters Symposium A part of the IPWatchdog Institute

AkzoNobel Aerospace Coatings. Global Training Program

SPONSORSHIP OPPORTUNITIES

Innovation policy mixes and implications on HEIs - emerging conclusions from the OECD innovation policy reviews

Observations from Pharma

European companies outpace American counterparts in R&D investment growth for the first time in five years

Plasma Chemistry and Plasma Processing November 13-14, 2017 Vienna, Austria

NG16: Content and schedule overview

Remote participation in Question sessions Audio options VoIP

Pro IPLIFESCIENCES. MEDIA KIT 2015

Patients Must Have Immediate Access to Affordable Generic Medicines at Day One After Patent Expiry

Conference March 8-9, 2018 Lexington

October 4 6, Session IV. Do Patent Prosecution Rules and Practices lead to Legal and Commercial Uncertainty?

CRC Association Conference

GLOBAL PRO BONO REPORT. Law is essential to creating a just society, but law does not create justice by itself.

Magalie Wasem Tréguer. Executive Summary. Säntisstrasse 93, 8820 Wädenswil, Switzerland +41 (0) / +41 (0)

Patented Medicine Prices Review Board P M P R B GUIDELINES REFORM. 15 th Annual Market Access Summit. Douglas Clark Executive Director PMPRB

2017 POST SHOW REPORT

PHARMA LAWCONVENTION

Biometrics and Standardization. Presentation to BioSec 2nd Open Workshop, 19th and 20th January, 2005

English - Or. English NUCLEAR ENERGY AGENCY COMMITTEE ON THE SAFETY OF NUCLEAR INSTALLATIONS FINAL REPORT AND ANSWERS TO QUESTIONNAIRE

William E. Solander. Case Highlight

SPONSORSHIP OPPORTUNITIES

IIPTA. Role of Intellectual Property Rights in Biotechnology Industry. Launch a Career. Be Awesome

Patent Masters Symposium

48 RobecoSAM The Sustainability Yearbook RobecoSAM Industry Leaders 2016

General Questionnaire

TECHNOLOGY VISION 2017 IN 60 SECONDS

Patent Masters Symposium A part of the IPWatchdog Institute

Life Sciences Regulatory

Venture Capital Report

A 5,000-square-meter surface. 45 employees

Table of Contents Executive Summary 29

Pergamon Corporation CONFRENCE

OECD Science, Technology and Industry Outlook 2008: Highlights

Follow-up from WEILBURGER Graphics at interpack and IST UV-Days

Encapsulated Transformers 115V + 115V Primary, Low Profile

Protection of Biological Materials in India Patent Truths and Untruths

International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs

Innovation in Europe: Where s it going? How does it happen? Stephen Roper Aston Business School, Birmingham, UK

Frame through-beam sensors

Global Events. Solar Storage Finance Future Grids

HOTELIER MALDIVES GM FORUM 2019

Through-beam ring sensors

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Carol E. Thorstad-Forsyth Partner

Koen Dejonckheere. Professional experience. Board Memberships. Education

Stress Calibration for Jitter >1UI A Practical Method

Economic and Social Council

DIGITALISING MANUFACTURING CONFERENCE 2017

STEVAL-ISQ010V1. High-side current-sense amplifier demonstration board based on the TSC102. Features. Description

Power Measurement and Analysis Software

Transcription:

C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack

C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics, healthcare and chemicals operate in a world of uncertainty. Issues around cost and pricing, clinical and operational innovation, customer and consumer engagement and regulatory compliance are spiralling. In addition, new and evolving technology advancements have primed the life sciences sector for disruption. Each year brings changes and challenges which companies must learn to adapt to and thrive in. C5 s life sciences portfolio brings together global industry leaders to discuss and debate the continuing challenges in the field. Covering key jurisdictions, this series remains the go-to place for the life sciences community to better understand key legal, compliance and business challenges as well as network with in-house and private practice professionals. Over the last decade the conferences have provided unrivalled expert insight into the latest developments in patents, regulatory and IP law in the global life science industry. We look forward to welcoming you to one of our future events to experience everything for yourself! WHY SPONSOR? Position your firm as a thought leader by: NETWORKING with key industry players through branding, diverse networking formats and drinks receptions SHOWCASING your products and services and the advantages that they bring through exhibiting HIGHLIGHTING your market knowledge and expertise by speaking, moderating a panel session or leading a focused roundtable CREATING commercial opportunities that maximise your ROI SPONSORSHIP PARTNER OPPORTUNITIES Branding Lanyard sponsor Conference Bags sponsor Delegate Note Pad & Stationary sponsor Conference materials sponsor Technology sponsor: Wifi sponsor; Memory Stick sponsor; Technology demo sponsor Series sponsor Presenting sponsor Thought Leadership Opportunities Chairing Lead/Headline sponsor Breakfast briefing sponsor Plenary session speaker Panel speaker Panel moderator Build your own panel Breakfast sponsor Refreshments breaks sponsor Luncheon sponsor Drinks reception sponsor Networking Roundtable leader Q&A/interview with keynote speaker Workshop leader Audience polling sponsor Innovation session Speaker Dinner sponsor Networking Dinner sponsor Private Dinner sponsor Networking Cruise/event sponsor 1 to 1 meetings Content Feature video partner Thought leadership partner Industry Report Sponsorship & Thought Leadership Partner Advisory board sponsor Lunchtime clinic sponsor Rising star sponsor Exhibiting Dedicated exhibition space in the networking area

10TH PHARMA & BIOTECH PATENT LITIGATION CONGRESS Explore the complex and continually contentious legal landscape of patent litigation in the pharma and biotech sphere FEBRUARY C5 s 10th PHARMA & BIOTECH PATENT LITIGATION Our conference focuses on litigation strategies for Pharma and Biotech companies in Europe, how they respond to patent challenges and conduct themselves in patent infringement actions. We feature all aspects of litigation, and how it is dealt with by in-house counsel and their private practice advisors. With a large audience generating an engaged and spirited atmosphere, a focus of the conference will fall on creating unique and meaningful networking opportunities. LAST YEAR S FACT: MORE THAN 15 COUNTRIES REPRESENTED + 40+ SPEAKERS x2 OVER 8 HOURS OF NETWORKING Delegates Breakdown by Country United Kingdom 38% Netherlands 33% Denmark 11% Germany 22% Canada 6% United States 8% Portugal Russian Federation 2% Belgium 5% France 11% Turkey 2% Italy 6% Switzerland 10% Spain 8% Rest of Europe 10% Rest of the World 5% Brazil 7% India 8% Very interesting, size of group was excellent. Dr Margrit Hillmann Bayer HealthCare

17 TH PHARMA PATENT TERM EXTENSIONS FORUM Extending Pharmaceutical Patent lifecycles to foster innovation and growth MAY INTERNATIONAL FORUM ON Pharma Patent Term Extensions Europe s ONLY specialist forum for all SPC and Patent Extensions Developments around the world! The best and most comprehensive conference in the European market solely dedicated to all developments in the world of SPC s and pharmaceutical patent term extensions. Our core group of delegates consistently return year on year for the cutting edge analysis and topical discussion they are guaranteed to receive. A cross section of top industry and private practice patent extension experts rely on this forum to provides necessary opportunities both to benchmark and to interact with key figures from Europe s leading patent offices and regulatory bodies. For sponsoring partners, this niche forum is distinct from other pharma and patent events. The key subject matter remains extremely focused and is not diluted or lost amongst the vast range of pharma or patent issues that dominate other events. These are the titles in attendance: European Patent Attorney Patent Attorney European Patent and Trademark Attorney Corporate Vice President Patent Strategies Patent Professional Senior Patent Counsel Delegates Breakdown by Country Very interactive and great examples of case law. Sakura Holloway, Benitec Biopharma United Kingdom 35% Netherlands 9% Sweden 10% Denmark 15% France 7% Germany 45% Belgium 9% Switzerland 10% Rest of Europe 15% Rest of the World 22% The hottest topics were covered by high level speakers and the networking opportunities were great. Nicolas Ruiz, Esteve

5TH LIFE SCIENCES IP SUMMIT Powering Business Growth through Practical and Innovative Patent Monetisation and Protection Strategies OCTOBER Life Sciences IP Summit 2018 Over four years, Life Sciences IP Summit is a culmination of the industry-leading portfolio of intellectual property events for the life sciences sector. The Life Sciences IP Summit brings together IP Directors, Heads of IP and Patent Counsel/ Attorneys from multinational companies. This Summit provides exclusive benchmarking and networking opportunities offering unparalleled access to the leading Life Sciences companies in Europe. OVERVIEW OF LIFE SCIENCES IP SUMMIT EDITIONS NEARLY 40 DIFFERENT COMPANIES 15 COUNTRIES REPRESENTED MAJORITY OF ATTENDEES ARE FROM MULTINATIONAL LIFE SCIENCES CORPORATIONS Delegates Breakdown by Country United Kingdom 76% Netherlands 22% Sweden Ireland 3% Norway Denmark 15% Canada 5% United States 11% France 7% Spain 9% Rest of Europe 7% Germany 53% Belgium 20% Poland Russian Federation 9% Czech Republic 3% Italy 15% Switzerland 28% India Australia 6% Rest of the World 11%

The past 5 years have seen attendees from: 40+ 700+ 60+ countries attendees across Life Sciences Companies DON T JUST TAKE OUR WORD FOR IT! LIFE SCIENCES SERIES PARTNERS INCLUDE:

GLOBAL CORPORATIONS THAT ATTENDED IN THE PAST INCLUDE: Ablynx ActogeniX NV Alcon Alkermes Pharma Ireland Ltd Allen & Overy Almirall SA argen X Astrazeneca Bayer Benitec Biopharma BioInvent International Boehringer Ingelheim Chemo Group Cipla Limited CSL Behring Cytos Biotechnology AG Debiopharm Delenex Therapeutics DeltaPatents Dompe Farmaceutici SpA Dompe Spa Eli Lilly Benelux Esteve Group F Hoffmann La Roche Ltd Farmaprojects Ferring Pharmaceuticals AS Ganymed Pharmaceuticals AG Gilead Sciences Ltd GlaxoSmithKline Hoffman La Roche AG Immunocore Ltd Kymab Laboratorios Dr. Esteve LEO Pharma AS Lundbeck Pharma AS Medichem SA Medimmune Merus BV Monsanto MorphoSys AG Mundipharma International NIBSC NBE Therapeutics Nestle Institute of Health Sciences Novartis Pharma AG Novo Nordisk AS Pfizer Ltd Polpharma Group Sandoz International GmbH Sanofi-Aventis Scil Proteins GmbH Syngenta Teva Pharmaceuticals Ltd TEVA UK Ltd Thermo Fisher Scientific TiGenix Trevisan & Cuonzo UCB Pharma SA Zealand Pharma Zentiva ks

Expand customer networks... Build brand equity... Make a lasting impression... TO DISCUSS YOUR BESPOKE SPONSOR PACKAGE please contact: SOFIANE GUERNI S.Guerni@C5-Online.com +44 (0) 20 7878 6870